Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis

Helicobacter

Volumn 12, Issue 4, 2007, Pages 306-308

  Hong, Liu ^a   Zhao, Yunping ^a,b   Han, Ying ^a   Guo, Wei ^a,b   Wang, Jun ^a   Li, Xiaohua ^a   Han, Yu ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adult; Cirrhosis; Helicobacter pylori; Human; Migraine

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; ARTERIOLE; ARTICLE; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; ERADICATION THERAPY; FEMALE; FREQUENCY ANALYSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; MALE; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT OUTCOME;

ADULT; AMOXICILLIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OMEPRAZOLE; TIME FACTORS; TREATMENT OUTCOME;

HELICOBACTER PYLORI; HEPATITIS B VIRUS;

EID: 34547555489     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00512.x     Document Type: Article

References (23)

1. Kang J, Blaser MJ. Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pylori. Nat Rev Microbiol 2006 4 : 826 36.
2. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006 19 : 449 90.
3. Kuipers EJ, Sipponen P. Helicobacter pylori eradication for the prevention of gastric cancer. Helicobacter 2006 11 : 52 7.
4. Festi D, Vestito A, Mazzella G, Roda E, Colecchia A. Management of hepatic encephalopathy: focus on antibiotic therapy. Digestion 2006 73 : 94 101.
5. Stewart CA, Reivich M, Lucey MR, Gores GJ. Neuroimaging in hepatic encephalopathy. Clin Gastroenterol Hepatol 2005 3 : 197 207.
6. Mullen KD, Dasarathy S. Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma? J Hepatol 2004 41 : 147 8.
7. Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 2006 19 : 597 613.
8. Velin D, Michetti P. Immunology of Helicobacter pylori infection. Digestion 2006 73 : 116 23.
9. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006 6 : 699 709.
10. Matysiak-Budnik T, Laszewicz W, Lamarque D, Chaussade S. Helicobacter pylori and non-malignant diseases. Helicobacter 2006 11 : 27 31.
11. Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di Sciascio G. Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am Heart J 2006 151 : 1215 22.
12. Gasbarrini A, Serricchio M, Tondi P, et al. Helicobacter pylori infection and vascular diseases. Ital J Gastroenterol Hepatol 1998 30 : S307 9.
13. Tunca A, Ardicoglu Y, Kargili A, Adam B. Migraine, Helicobacter pylori, and oxidative stress. Helicobacter 2007 12 : 59 62.
14. Pinessi L, Savi L, Pellicano R, Rainero I, Valfre W, Gentile S, Cossotto D, Rizzetto M, Ponzetto A. Chronic Helicobacter pylori infection and migraine: a case-control study. Headache 2000 40 : 836 9.
15. Yusuf SW, Mishra RM. Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta Cardiol 2002 57 : 317 22.
16. Wang G, Hong Y, Johnson MK, Maier RJ. Lipid peroxidation as a source of oxidative damage in Helicobacter pylori protective roles of peroxiredoxins. Biochim Biophys Acta 2006 1760 : 1596 603.
17. Papatheodoridis GV, Sougioultzis S, Archimandritis AJ. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 2006 4 : 130 42.
18. Dzierzanowska-Fangrat K, Lehours P, Megraud F, Dzierzanowska D. Diagnosis of Helicobacter pylori infection. Helicobacter 2006 11 : 6 13.
19. Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori diagnosis and management. Gastroenterol Clin North Am 2006 35 : 229 47.
20. Pflock M, Kennard S, Finsterer N, Beier D. Acid-responsive gene regulation in the human pathogen Helicobacter pylori. J Biotechnol 2006 126 : 52 60.
21. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006 11 : 75 80.
22. Correa P. Does Helicobacter pylori cause gastric cancer via oxidative stress? Biol Chem 2006 387 : 361 4.
23. Suzuki T, Matsuo K, Sawaki A, et al. Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2006 24 : 273 80.